Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation
Liver International · 2024
DOI: 10.1111/liv.15936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Chenxi Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Inflammatory Biology, The Province and Ministr…. Hauptthemen laut MEDLINE: Ferroptosis, Liver Diseases, Alcoholic, Mice, Knockout, Disease Models, Animal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Background and Aims Iron overload, oxidative stress and ferroptosis are associated with liver injury in alcohol‐associated liver disease (ALD), however, the crosstalk among these regulatory pathways in ALD development is unclear.
Methods
ALD mouse model and general control of amino acid synthesis 5 like 1 (GCN5L1) liver knockout mice were generated to investigate the role of GCN5L1 in ALD development. Proteomic screening tests were performed to identify the key factors mediating GCN5L1 loss‐induced ALD.
Results
Gene Expression Omnibus data set analysis indicates that GCN5L1 expression is negatively associated with ALD progression. GCN5L1 hepatic knockout mice develop severe liver injury and lipid accumulation when fed an alcohol diet. Screening tests identified that GCN5L1 targeted the mitochondrial iron transporter CISD1 to regulate mitochondrial iron homeostasis in ethanol‐induced ferroptosis. GCN5L1‐modulated CISD1 acetylation and activity were crucial for iron accumulation and ferroptosis in response to alcohol exposure.
Conclusion
Pharmaceutical modulation of CISD1 activity is critical for cellular iron homeostasis and ethanol‐induced ferroptosis. The GCN5L1/CISD1 axis is crucial for oxidative stress and ethanol‐induced ferroptosis in ALD and is a promising avenue for novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Inflammatory Biology, The Province and Ministry Co-Sponsored Collaborative Innovation Centre for Medical Epigenetics…
- Tianjin Key Laboratory of Cell Homeostasis and Major Diseases, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
- National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Chenxi Yang, Lu Zhu, Lingdi Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Yang, C., Yang, Y., Hu, X., Tang, Q., Zhang, J., Zhang, P., Lu, X., Xu, J., Li, S., Dong, Z., Zhu, L., & Wang, L. (2024). Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation. Liver International. https://doi.org/10.1111/liv.15936
Vancouver
Yang C, Yang Y, Hu X, Tang Q, Zhang J, Zhang P, et al. Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation. Liver International. 2024. doi:10.1111/liv.15936
BibTeX
@article{Yang2024,
author = {Yang, Chenxi and Yang, Ye and Hu, Xiuya and Tang, Qiqi and Zhang, Jiaqi and Zhang, Peiyu and Lu, Xin and Xu, Juan and Li, Sai and Dong, Zhengni and Zhu, Lu and Wang, Lingdi},
title = {Loss of GCN5L1 exacerbates damage in alcoholic liver disease through ferroptosis activation},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15936}
}
EUVIMED